Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bosentan monohydrate, quantity: 129.083 mg - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; sodium starch glycollate type a; pregelatinised maize starch; povidone; glycerol dibehenate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose - bosentan is indicated for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: maize starch; pregelatinised maize starch; sodium starch glycollate type a; povidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 64.54 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; pregelatinised maize starch; magnesium stearate; sodium starch glycollate type a; povidone; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; povidone; maize starch; magnesium stearate; sodium starch glycollate type a; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - bosentan monohydrate, quantity: 64.54 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; magnesium stearate; sodium starch glycollate type a; povidone; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red - bosentan gh is indicated for the treatment of ? idiopathic pulmonary arterial hypertension ? familial pulmonary arterial hypertension ? pulmonary arterial hypertension associated with scleroderma or ? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger?s physiology,in patients with who functional class ii, iii or iv symptoms.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - hydrochlorothiazide; losartan potassium - film-coated tablet - 50/12.5 milligram(s) - angiotensin ii antagonists and diuretics; losartan and diuretics

Kenya - English - Pharmacy and Poisons Board

aristo pharmaceuticals pvt.ltd 23-a, shah industrial estate, off veera desai - losartan potassium & hydrochlorothiazide 50/12.5 - film-coated tablet - losartan potassium & hydrochlorothiazide 50/12.5 - losartan and diuretics

Kenya - English - Pharmacy and Poisons Board

hetero labs limited 7-2-a2 hetero corporate industrial estates sanath - losartan potassium (form-i) - film-coated tablet - each film coated tablet containslosartan… - agents acting on the renin-angiotensin system:

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - losartan potassium - film-coated tablet - 100 milligram(s) - angiotensin ii antagonists, plain; losartan

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - losartan potassium - film-coated tablet - 50 milligram(s) - angiotensin ii antagonists, plain; losartan